Fate and transport of carbamazepine in soil aquifer treatment (SAT) infiltration basin soils

The transport and fate of the pharmaceutical carbamazepine (CBZ) were investigated in the Dan Region Reclamation Project (SHAFDAN), Tel-Aviv, Israel. Soil samples were taken from seven subsections of soil profiles (150 cm) in infiltration basins of a soil aquifer treatment (SAT) system. The transport characteristics were studied from the release dynamics of soil-resident CBZ and, subsequently, from applying a pulse input of wastewater containing CBZ. In addition, a monitoring study was performed to evaluate the fate of CBZ after the SAT. Results of this study indicate adsorption, and consequently retardation, in CBZ transport through the top soil layer (0-5 cm) and to a lesser extent in the second layer (5-25 cm), but not in deeper soil layers (25-150 cm). The soluble and adsorbed fractions of CBZ obtained from the two upper soil layers comprised 45% of the total CBZ content in the entire soil profile. This behavior correlated to the higher organic matter content observed in the upper soil layers (0-25 cm). It is therefore deduced that when accounting for the full flow path of CBZ through the vadose zone to the groundwater region, the overall transport of CBZ in the SAT system is essentially conservative. The monitoring study revealed that the average concentration of CBZ decreased from 1094 ± 166 ng L⁻¹ in the recharged wastewater to 560 ± 175 ng L⁻¹ after the SAT. This reduction is explained by dilution of the recharged wastewater with resident groundwater, which may occur as it flows to active reclamation wells.     

Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana

A number of pharmaceutically active compounds (PhACs) have been detected in the aquatic environment as a result of discharges of municipal wastewater. In the state of Louisiana, USA, many municipalities treat wastewater using natural systems, such as lagoons and wetlands, rather than conventional wastewater treatment technologies. Nearly all research to date has focused on the fate of PhACs in conventional treatment plants, not constructed and natural wetlands. In the wastewater treatment plant (WWTP) for Mandeville, Louisiana, USA, wastewater flows of 7600 m³ d⁻¹ are treated in a series of aeration lagoons (basins), followed by a constructed wetland and UV disinfection, before being discharged into a natural forested wetland (i.e. Bayou Chinchuba) and eventually, Lake Pontchartrain. Thirteen out of the 15 PhACs investigated were detected in the wastewater inflow to the treatment plant. Only 9 of the 13 compounds were above the detection limits at the treatment plant effluent. The concentrations of most compounds were reduced by greater than 90% within the plant, while carbamazepine and sotalol were only reduced by 51% and 82%, respectively. The percent reductions observed in the Mandeville system were greater than reduction rates reported for conventional WWTPs; perhaps due to the longer treatment time (30 days). Most target PhACs were not completely removed before discharge into Lake Pontchartrain, although their collective annual loading was reduced to less than 1 kg and down to ppb with significant potential for dilution in the large lake.     

Fecal coliforms, caffeine and carbamazepine in stormwater collection systems in a large urban area

Water samples from streams, brooks and storm sewer outfall pipes that collect storm waters across the Island of Montréal were analyzed for caffeine, carbamazepine and fecal coliforms. All samples contained various concentrations of these tracers, indicating a widespread sanitary contamination in urban environments. Fecal coliforms and caffeine levels ranged over several orders of magnitude with a modest correlation between caffeine and fecal coliforms (R² value of 0.558). An arbitrary threshold of 400 ng caffeine L⁻¹ allows us to identify samples with an elevated fecal contamination, as defined by more than 200 colony-forming units per 100 mL (cfu 100 mL⁻¹) of fecal coliforms. Low caffeine levels were sporadically related to high fecal coliform counts. Lower levels of caffeine and fecal coliforms were observed in the brooks while the larger streams and storm water discharge points contained over ten times more. The carbamazepine data showed little or no apparent correlation to caffeine. These data suggest that this storm water collection system, located in a highly urbanized urban environment, is widely contaminated by domestic sewers as indicated by the ubiquitous presence of fecal contaminants as well as caffeine and carbamazepine. Caffeine concentrations were relatively well correlated to fecal coliforms, and could potentially be used as a chemical indicator of the level of contamination by sanitary sources. The carbamazepine data was not significantly correlated to fecal coliforms and of little use in this dataset.     

Presence of carbamazepine,naproxen, and ibuprofen in wastewater from northern Tunisia

We investigated the occurrence of three pharmaceutical residues in four wastewater treatment plants (WWTPs) from northern Tunisia. The selected compounds were carbamazepine, naproxen, and ibuprofen; they are among the most commonly prescribed and widely used pharmaceutical agents worldwide. Samples (200?mL) were pre-concentrated using the solid phase extraction (SPE) enrichment procedure and the analysis of the pharmaceuticals was performed with high-performance liquid chromatography (HPLC-UV). The overall procedure provided limits of detection (LOD) lower than 0.5 µg.L^?1and recoveries of 78–97%. For the carbamazepine compound, the mean concentrations were 60.58, 93.19, and 132 µg.L^?1 for the Bizerte, Jendouba, and Tunis WWTPs, respectively. This pharmaceutical was not detected in the Beja WWTPs. Naproxen and ibuprofens were not detected in the Jendouba WWTP but were found in the three other WWTPs with concentrations ranging from 2.94 to 36.17 µg.L^?1 and from 8.02 to 43.22 µg.L^?1, respectively. From the obtained data, it seems that these WWTPs are not able to eliminate this kind of micro-pollutants.     

针对优选药物的水质指南导引

药物会进入淡水系统并影响水生态系统的健康。即使广泛应用的药物已经过毒性检测,以证据为基础的水质标准依然没有制定出。将BurrIII型分布应用于慢性毒性数据的物种敏感度分布(SSD),我们得到了卡马西平、双氯芬酸、氟西汀和美托洛尔4种药物在淡水中高度可靠的水质标准指引值(GV)。数据经过质检并且符合慢性无观察效应浓度(NOEC)或是10%有效浓度(即影响到10%的物种)要求,其终点与种群相关,效应指标为发育、生长、生殖与存活状况。由于生物标记物的回应(例如生化、组织及分子回应)与野生种群相关的影响并不存在直接的联系,故得出的相关数据并未考虑在内。在保护95%物种的范围内,得出卡马西平、双氯芬酸、氟西汀和美托洛尔4种药物的GV分别为4.3,770,1.6和14 μg?L^L-1。广泛应用在欧盟委员会、瑞士与德国的GV则是基于有限数据库中最敏感的实验终点 (可能包括生化、组织及分子生物标记物的回应)。本实验得出的GV显著高于这些可靠性未知的GV。
精选自Anupama Kumar, Graeme E. Batley, Bhanu Nidumolu, Thomas H. Hutchinson. Derivation of water quality guidelines for priority pharmaceuticals. Environmental Toxicology and Chemistry: Volume 35, Issue 7, pages 1815–1824, July 2016. DOI: 10.1002/etc.3336
详情请见http://onlinelibrary.wiley.com/doi/10.1002/etc.3336/full